Evidence map›Paper›PMID 26813606›Full record

ArticleScientific reports2016

Col4a1 mutations cause progressive retinal neovascular defects and retinopathy.

Marcel V Alavi, Mao Mao, Bradley T Pawlikowski, Manana Kvezereli, Jacque L Duncan, Richard T Libby, Simon W M John, Douglas B Gould

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Skeletal pathology in mouse models of Gould syndrome is partially alleviated by genetically reducing TGFβ signaling.Matrix biology : journal of the International Society for Matrix Biology · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Elevated TGFβ signaling contributes to cerebral small vessel disease in mouse models of Gould syndrome.Matrix biology : journal of the International Society for Matrix Biology · 2023
    Article
  12. Article
  13. Prolyl 3-Hydroxylase 2 Is a Molecular Player of Angiogenesis.International journal of molecular sciences · 2021
    Article
  14. Article
  15. Article
  16. The pericyte microenvironment during vascular development.Microcirculation (New York, N.Y. : 1994) · 2019
    Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Marcel V AlaviDepartment of Ophthalmology, School of Medicine, University of California, San Francisco, San Francisco, CA, 94143.
Mao MaoDepartment of Ophthalmology, School of Medicine, University of California, San Francisco, San Francisco, CA, 94143.
Bradley T PawlikowskiDepartment of Ophthalmology, School of Medicine, University of California, San Francisco, San Francisco, CA, 94143.
Manana KvezereliDepartment of Ophthalmology, School of Medicine, University of California, San Francisco, San Francisco, CA, 94143.
Jacque L DuncanDepartment of Ophthalmology, School of Medicine, University of California, San Francisco, San Francisco, CA, 94143.
Richard T LibbyDepartment of Ophthalmology, University of Rochester, Rochester, NY, 14642.
Simon W M JohnHoward Hughes Medical Institute and The Jackson Laboratory, Bar Harbor, ME 04609.
Douglas B GouldDepartment of Ophthalmology, School of Medicine, University of California, San Francisco, San Francisco, CA, 94143.
University of California, San Francisco · USJackson Laboratory · USUniversity of Rochester · US

Funding

Rapid-Prototyping and Design CoreP30EY002162 · NEI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LAKKARAJU, APARNA · 1985 to 2024
$16.8M
Factors Determining Intraocular Pressure and Glaucoma SusceptibilityR01EY011721 · NEI · JACKSON LABORATORY · PI JOHN, SIMON W · 2002 to 2018
$12.4M
Genetically testing interactions of ER and oxidative stresses in retinal diseaseR01EY019514 · NEI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GOULD, DOUGLAS · 2009 to 2013
$1.9M
FACTORS DETERMINING INTRAOCULAR PRESSURER29EY011721 · NEI · JACKSON LABORATORY · PI JOHN, SIMON W · 1997 to 2001
$227k
NEI NIH HHS EY019514NEI NIH HHS EY11721NEI NIH HHS P30 EY002162NEI NIH HHS R01 EY011721NEI NIH HHS R01 EY019514
6 · The paper itself

Abstract

Mutations in collagen, type IV, alpha 1 (COL4A1), a major component of basement membranes, cause multisystem disorders in humans and mice. In the eye, these include anterior segment dysgenesis, optic nerve hypoplasia and retinal vascular tortuosity. Here we investigate the retinal pathology in mice carrying dominant-negative Col4a1 mutations. To this end, we examined retinas longitudinally in vivo using fluorescein angiography, funduscopy and optical coherence tomography. We assessed retinal function by electroretinography and studied the retinal ultrastructural pathology. Retinal examinations revealed serous chorioretinopathy, retinal hemorrhages, fibrosis or signs of pathogenic angiogenesis with chorioretinal anastomosis in up to approximately 90% of Col4a1 mutant eyes depending on age and the specific mutation. To identify the cell-type responsible for pathogenesis we generated a conditional Col4a1 mutation and determined that primary vascular defects underlie Col4a1-associated retinopathy. We also found focal activation of Müller cells and increased expression of pro-angiogenic factors in retinas from Col4a1(+/Δex41)mice. Together, our findings suggest that patients with COL4A1 and COL4A2 mutations may be at elevated risk of retinal hemorrhages and that retinal examinations may be useful for identifying patients with COL4A1 and COL4A2 mutations who are also at elevated risk of hemorrhagic strokes.

Indexed as

MutationAnimalsCollagen Type IVDisease Models, AnimalDisease ProgressionMiceMice, KnockoutOphthalmoscopesPhenotypeRetinaRetinal DiseasesTomography, Optical CoherenceCollagen Type IV

Identifiers

PMID26813606
PMCPMC4728690
OpenAlexW2263313044

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.